These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2687943)

  • 21. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis.
    Stanford JL; Rook GA; Bahr GM; Dowlati Y; Ganapati R; Ghazi Saidi K; Lucas S; Ramu G; Torres P; Minh Ly H
    Vaccine; 1990 Dec; 8(6):525-30. PubMed ID: 2087873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy and immunoprophylaxis of leprosy.
    Convit J; Ulrich M
    Indian J Lepr; 2000; 72(1):21-32. PubMed ID: 10935184
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotherapy in leprosy.
    Fusaro RM
    JAMA; 1982 Dec; 248(21):2833. PubMed ID: 7143640
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycobacterium w immunotherapy in leprosy.
    Whitty C
    Lepr Rev; 1998 Sep; 69(3):222-4. PubMed ID: 9805877
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapy of leprosy.
    Katoch K
    Indian J Lepr; 1996; 68(4):349-61. PubMed ID: 9001903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modern leprosy treatment.
    AUSTIN CJ
    Lepr Rev; 1954 Oct; 25(4):174-8. PubMed ID: 13222922
    [No Abstract]   [Full Text] [Related]  

  • 27. Result of marianum antigen in the treatment of leprosy.
    Bagalawis A; Oh E; Whang M
    Lepr Rev; 1966 Jan; 37(1):51-5. PubMed ID: 5908577
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isonicotinic acid hydrazide in cutaneous tuberculosis and leprosy].
    BERTACCINI G
    Ann Ital Dermatol Sifilogr; 1953; 8(1):5-9. PubMed ID: 13058248
    [No Abstract]   [Full Text] [Related]  

  • 29. Comment: reversal reaction in multibacillary leprosy patients following MDT with and without immunotherapy with a candidate for an antileprosy vaccine, Mycobacterium W. H. K. Kar et al.
    van Brakel WH
    Lepr Rev; 1994 Dec; 65(4):404-5. PubMed ID: 7861929
    [No Abstract]   [Full Text] [Related]  

  • 30. Transfer factor and lepromatous leprosy.
    N Engl J Med; 1973 Apr; 288(14):740-2. PubMed ID: 4688384
    [No Abstract]   [Full Text] [Related]  

  • 31. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy.
    Bullock WE; Fields JP; Brandriss MW
    N Engl J Med; 1972 Nov; 287(21):1053-9. PubMed ID: 4562439
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunotherapeutic trials with a candidate anti-leprosy vaccine based on Mycobacterium w.
    Talwar GP; Zaheer SA; Suresh NR; Parida SK; Mukherjee R; Singh IG; Sharma AK; Kar HK; Misra RS; Mukherjee A
    Trop Med Parasitol; 1990 Sep; 41(3):369-70. PubMed ID: 2255867
    [No Abstract]   [Full Text] [Related]  

  • 33. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.
    Meyers WM; McDougall AC; Fleury RN; Neves R; Reyes O; Binford CH
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):302-9. PubMed ID: 3045226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for new interventions in the treatment and prevention of mycobacterial disease.
    Young DB; Duncan K
    Annu Rev Microbiol; 1995; 49():641-73. PubMed ID: 8561475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
    Convit J; Aranzazu N; Ulrich M; Pinardi ME; Reyes O; Alvarado J
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J; Stanford C; Grange J
    Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Result of studies of immunotherapy of lepromatous leprosy and borderline leprosy].
    Saint-André P; Baquillon G; Ferracci C; Ridel PR
    Acta Leprol; 1981; (84):39-55. PubMed ID: 6797222
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early results of isonicotinic acid hydrazide therapy of cutaneous and testicular tuberculosis and of leprosy].
    GRASSI A
    Rass Dermatol Sifilogr; 1952; 5(2):107-10. PubMed ID: 13027592
    [No Abstract]   [Full Text] [Related]  

  • 39. BCG vaccination in leprosy.
    Noordeen SK
    Dev Biol Stand; 1986; 58 ( Pt A)():287-92. PubMed ID: 3297867
    [No Abstract]   [Full Text] [Related]  

  • 40. Vaccine development in leprosy.
    Saha K
    Int J Lepr Other Mycobact Dis; 1977; 45(3):297-8. PubMed ID: 336561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.